Lucid Diagnostics Inc. 13F holders
115 funds reported a position in Lucid Diagnostics Inc. in their 13F for the quarter ended 30 June 2026, together 61.4 million shares worth $65.7 million. Against the quarter before, 24 opened a position, 59 added, 12 trimmed and 10 sold out; together they bought a net 26.7 million shares. The largest holders: Alyeska Investment Group, L.P., BlackRock, Inc. and Vanguard Capital Management LLC.
What each fund did in LUCD against its 13F for the quarter before; a change under 0.1% of a holding counts as held
Funds reporting a position in LUCD in their 13F, each quarter; hover a bar for the shares they held
Filed so far for the quarter to 30 September 2026
3,405 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 22 reported a position in Lucid Diagnostics Inc.: 3 opened one, 4 added, 7 trimmed and 4 sold out, a net 71,286 shares sold.
| Fund | Change in shares | Shares now | Status | Filing |
|---|---|---|---|---|
| Sax Wealth Advisors, LLC | +25,287 | 25,287 | new | 13F |
| Axxcess Wealth Management, LLC | +18,254 | 18,254 | new | 13F |
| Magnus Financial Group LLC | -14,500 | 40,900 | trimmed | 13F |
| Anchyra Partners LLC | +11,589 | 11,589 | new | 13F |
| Oppenheimer & Co. Inc. | +10,000 | 40,000 | added | 13F |
| Farther Finance Advisors, LLC | +8,926 | 9,167 | added | 13F |
| Sterling Capital Management LLC | +4,355 | 4,877 | added | 13F |
| Essential Partners LLC | -527 | 40 | trimmed | 13F |
| SJS Investment Consulting Inc. | -330 | 16 | trimmed | 13F |
| Gamma Investing LLC | +325 | 467 | added | 13F |
| True Wealth Design, LLC | -126 | 113 | trimmed | 13F |
| IFP Advisors, Inc | -105 | 52 | trimmed | 13F |
| ProShare Advisors LLC | -51 | 19,417 | trimmed | 13F |
| Fortitude Family Office, LLC | -39 | 196 | trimmed | 13F |
| Kestra Private Wealth Services, LLC | -14,000 | 0 | sold out | 13F |
| State of Wyoming | -93,927 | 0 | sold out | 13F |
| Wealth Enhancement Advisory Services, LLC | -26,393 | 0 | sold out | 13F |
| Wealth Enhancement Trust Services, Inc. | -24 | 0 | sold out | 13F |
The largest moves in the name among the funds that have filed, against each fund's previous 13F.
The well-known funds
Of the 44 funds followed here, 5 reported a position in Lucid Diagnostics Inc. in a 13F for the quarter ended 30 June 2026. The largest: Alyeska, 8.9 million shares worth $9.5 million, 0.0% of its reported book. New this quarter: Alyeska, Citadel Advisors. Sold out: Millennium Management. In the quarter, 3 funds added or opened a position and 3 trimmed or sold out; together they bought a net 9.9 million shares, about $10.6 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Alyeska | 8,856,844 | $9.5 million | 0.0% | +8,856,844 | new | 30 June 2026 | 13F |
| Geode Capital Management | 3,789,948 | $4.1 million | 0.0% | +1,544,598 | added | 30 June 2026 | 13F |
| Renaissance Technologies | 71,300 | $76,291 | 0.0% | -428,361 | trimmed | 30 June 2026 | 13F |
| Citadel Advisors | 36,362 | $38,907 | 0.0% | +36,362 | new | 30 June 2026 | 13F |
| FMR LLC | 4,215 | $4,510 | 0.0% | -116,354 | trimmed | 30 June 2026 | 13F |
| Millennium Management | 0 | $0 | 0.0% | -11,320 | exited | 30 June 2026 | 13F |
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.The largest holders
| Fund | Shares | Share of all | Value | Of its book | Change in shares | Filing |
|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 8,856,844 | 14.42% | $9.5 million | 0.02% | new | 13F |
| BlackRock, Inc. | 8,373,117 | 13.64% | $9.0 million | 0.00% | +3,734,874 | 13F |
| Vanguard Capital Management LLC | 6,556,344 | 10.68% | $7.0 million | 0.00% | +2,401,574 | 13F |
| Two Seas Capital LP | 6,000,000 | 9.77% | $6.4 million | 0.24% | +3,000,000 | 13F |
| Masters Capital Management LLC | 4,000,000 | 6.51% | $4.3 million | 0.60% | no change | 13F |
| Aberdeen Group plc | 3,822,997 | 6.23% | $4.1 million | 0.01% | +178,720 | 13F |
| Geode Capital Management, LLC | 3,789,948 | 6.17% | $4.1 million | 0.00% | +1,544,598 | 13F |
| State Street Corp. | 2,437,337 | 3.97% | $2.6 million | 0.00% | +882,756 | 13F |
| First Manhattan Co. LLC. | 2,188,550 | 3.56% | $2.3 million | 0.01% | +1,865,100 | 13F |
| Wells Fargo & Company | 2,067,046 | 3.37% | $2.2 million | 0.00% | +792,656 | 13F |
| Russell Investments Group, Ltd. | 1,651,788 | 2.69% | $1.8 million | 0.00% | +68,180 | 13F |
| Northern Trust Corp. | 1,219,879 | 1.99% | $1.3 million | 0.00% | +549,294 | 13F |
| Perkins Capital Management Inc. | 1,125,000 | 1.83% | $1.2 million | 0.91% | -1,000 | 13F |
| Vanguard Fiduciary Trust Co. | 1,068,109 | 1.74% | $1.1 million | 0.00% | +444,552 | 13F |
| Vanguard Portfolio Management LLC | 1,022,262 | 1.66% | $1.1 million | 0.00% | +493,493 | 13F |
| UBS Group AG | 845,314 | 1.38% | $904,486 | 0.00% | +399,835 | 13F |
| AQR Capital Management LLC | 723,200 | 1.18% | $773,824 | 0.00% | +488,431 | 13F |
| Raymond James Financial Inc. | 577,381 | 0.94% | $617,798 | 0.00% | +52,445 | 13F |
| Lido Advisors, LLC | 446,739 | 0.73% | $478,011 | 0.00% | +63,657 | 13F |
| Charles Schwab Investment Management Inc. | 325,312 | 0.53% | $348,084 | 0.00% | +127,888 | 13F |
| XML Financial, LLC | 323,195 | 0.53% | $345,819 | 0.03% | +100,000 | 13F |
| Bank of New York Mellon Corp | 301,703 | 0.49% | $322,823 | 0.00% | +95,397 | 13F |
| Bank of Montreal | 289,936 | 0.47% | $310,232 | 0.00% | +4,700 | 13F |
| Nuveen, LLC | 195,065 | 0.32% | $208,720 | 0.00% | +104,831 | 13F |
| Tripletail Wealth Management, LLC | 183,417 | 0.30% | $196,256 | 0.23% | new | 13F |
| Focus Partners Wealth | 148,705 | 0.24% | $159,114 | 0.00% | new | 13F |
| Deutsche Bank AG | 148,061 | 0.24% | $158,425 | 0.00% | +67,706 | 13F |
| LPL Financial LLC | 133,155 | 0.22% | $142,476 | 0.00% | -39,221 | 13F |
| Jefferies Financial Group Inc. | 130,000 | 0.21% | $139,100 | 0.00% | new | 13F |
| Price T Rowe Associates Inc. | 121,952 | 0.20% | $131,000 | 0.00% | +47,575 | 13F |
| Centiva Capital, LP | 109,440 | 0.18% | $117,101 | 0.00% | +40,377 | 13F |
| Bank of America Corp. | 96,776 | 0.16% | $103,550 | 0.00% | +8,249 | 13F |
| Ieq Capital, LLC | 95,543 | 0.16% | $102,231 | 0.00% | +80,833 | 13F |
| State of Wyoming | 93,927 | 0.15% | $100,502 | 0.01% | new | 13F |
| Sequoia Financial Advisors, LLC | 92,150 | 0.15% | $98,601 | 0.00% | new | 13F |
| Rhumbline Advisers | 84,083 | 0.14% | $89,964 | 0.00% | +35,453 | 13F |
| Invesco Ltd. | 82,754 | 0.13% | $88,547 | 0.00% | +44,828 | 13F |
| Renaissance Technologies LLC | 71,300 | 0.12% | $76,291 | 0.00% | -428,361 | 13F |
| Goldman Sachs Group Inc. | 70,611 | 0.11% | $75,554 | 0.00% | -172,047 | 13F |
| Citigroup Inc. | 69,793 | 0.11% | $74,679 | 0.00% | +65,376 | 13F |
| Mirae Asset Global ETFS Holdings Ltd. | 68,471 | 0.11% | $73,264 | 0.00% | +25,591 | 13F |
| Morgan Stanley | 65,743 | 0.11% | $70,345 | 0.00% | +19,706 | 13F |
| Sargent Investment Group, LLC | 65,000 | 0.11% | $69,550 | 0.01% | +10,970 | 13F |
| JPMorgan Chase & Co. | 62,775 | 0.10% | $65,914 | 0.00% | +7,127 | 13F |
| New York State Common Retirement Fund | 58,700 | 0.10% | $62,809 | 0.00% | no change | 13F |
| Traphagen Investment Advisors LLC | 58,590 | 0.10% | $62,692 | 0.00% | +29,295 | 13F |
| Marshall Wace, LLP | 57,893 | 0.09% | $61,946 | 0.00% | new | 13F |
| Magnus Financial Group LLC | 55,400 | 0.09% | $59,278 | 0.00% | new | 13F |
| AllianceBernstein L.P. | 47,200 | 0.08% | $54,280 | 0.00% | +25,000 | 13F |
| MML Investors Services, LLC | 50,000 | 0.08% | $53,500 | 0.00% | no change | 13F |
Read more
Share of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 9 February 2026 | 13D/A | PAVmed Inc. | 38.8 million | 27.5% | 3 February 2026 | The Reporting Person is the parent company of the Issuer. As a result of its ability to vote 27.5% of the Common Stock (and an estimated 26.3% of all the capital stock of the Issuer), the Reporting Person has the power to significantly infl | EDGAR |
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13GFails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 31 August 2026 | 6 | $0.99 | SEC |
| 20 August 2026 | 8,538 | $1.01 | SEC |
| 19 August 2026 | 18 | $0.99 | SEC |
| 18 August 2026 | 3,075 | $0.98 | SEC |
| 13 August 2026 | 10 | $0.98 | SEC |
| 10 August 2026 | 564 | $0.97 | SEC |
| 7 August 2026 | 564 | $0.95 | SEC |
| 6 August 2026 | 3,383 | $1.00 | SEC |
| 20 July 2026 | 6,633 | $0.95 | SEC |